Descrizione Clinica
RIGENOMA
WELCOME
Description
Bendage consists of an elastic support impregnated with Ozoile (Stable Ozonids). It is indicated to optimize the quality of the suffering skin and restore the good functional state. Reduces lymphatic and blood stasis, improves local microcirculation, promotes the absorption of possible hedges, optimizes scar management, prevents and counters the formation of cheloid. Ozoile protects, elasticizes and hydrates the underlying skin, yields oxygen, generates moderate oxidative stress that can regenerate tissues, contrasts degenerative processes. Ozoile creates a lipid film with a breathable barrier/protective effect and together with its oxidizing nature, it generates a microenvironment hostile to the pathogenic microbial proliferation and favorable to the activation of the microcirculation. The moderate oxidative stress generated by stable Ozonides, acting on RedOx balance, promotes tissue repair processes and proper scarring.
It represents an effective solution to support compromised skin and improve its functional recovery, ensuring protection and preventing further alterations. Ideal for compressed blindfolding, it is indicated in the phlebological field for conditions such as chronic venous inadequacy, passive edema, thrombophlebittes and phlebotrombosis. Ideal also on post surgical wounds.
Mode of use
Apply RIGENOMA BENDAGGIO with Ozoile with a decreasing compression from the foot or ankle to the calf. Avoid the formation of folds that can create further decubited injuries. Maintain the correct position of the limb during bandage. Secure bandage firmly without preventing movement. Cover the bandage with tubular or cotton of Germany and with self-adhesive or elastocompressive bandage.
In case of anelastic and non-elastocompressive application, use RIGENOMA BENDAGGIO starting from the head of metatarsi up to the peroneal apophysisis, with an overlap of 50%; once you have reached the peroneal apophysis, return to the foot using the whole bandage. Complete the packaging with German cotton and self-adhesive bandage with the same pattern described above.
Components
Ozoile (Stable Ozonids); elastic support: polyamide 30%/viscose 70%, elongation [%]: approx. 60%.
Warnings
Product intended for topical use. Don't swallow. Keep the product away from the reach of children. Do not use in case of damaged packaging. Do not use the device over the expiry date. The expiry date refers to the intact and properly preserved product. Wash your hands well before using your medical device. RIGENOMA BENDAGGIO with Ozoile is well tolerated. Awareness and side effects are not known today. Do not use in case of proven hypersensitivity to the product or some of its components; in case such phenomena occur it is indicated to suspend treatment and consult the doctor.
Conservation
Store in a cool and dry place from heat sources and direct sunlight. Preferably store between 5 °C and 35 °C.
Post-opening validation: six months.
Format
Pack containing 1 bandage of 10 cm x 5 m.
Cod. 51
Bendage consists of an elastic support impregnated with Ozoile (Stable Ozonids). It is indicated to optimize the quality of the suffering skin and restore the good functional state. Reduces lymphatic and blood stasis, improves local microcirculation, promotes the absorption of possible hedges, optimizes scar management, prevents and counters the formation of cheloid. Ozoile protects, elasticizes and hydrates the underlying skin, yields oxygen, generates moderate oxidative stress that can regenerate tissues, contrasts degenerative processes. Ozoile creates a lipid film with a breathable barrier/protective effect and together with its oxidizing nature, it generates a microenvironment hostile to the pathogenic microbial proliferation and favorable to the activation of the microcirculation. The moderate oxidative stress generated by stable Ozonides, acting on RedOx balance, promotes tissue repair processes and proper scarring.
It represents an effective solution to support compromised skin and improve its functional recovery, ensuring protection and preventing further alterations. Ideal for compressed blindfolding, it is indicated in the phlebological field for conditions such as chronic venous inadequacy, passive edema, thrombophlebittes and phlebotrombosis. Ideal also on post surgical wounds.
Mode of use
Apply RIGENOMA BENDAGGIO with Ozoile with a decreasing compression from the foot or ankle to the calf. Avoid the formation of folds that can create further decubited injuries. Maintain the correct position of the limb during bandage. Secure bandage firmly without preventing movement. Cover the bandage with tubular or cotton of Germany and with self-adhesive or elastocompressive bandage.
In case of anelastic and non-elastocompressive application, use RIGENOMA BENDAGGIO starting from the head of metatarsi up to the peroneal apophysisis, with an overlap of 50%; once you have reached the peroneal apophysis, return to the foot using the whole bandage. Complete the packaging with German cotton and self-adhesive bandage with the same pattern described above.
Components
Ozoile (Stable Ozonids); elastic support: polyamide 30%/viscose 70%, elongation [%]: approx. 60%.
Warnings
Product intended for topical use. Don't swallow. Keep the product away from the reach of children. Do not use in case of damaged packaging. Do not use the device over the expiry date. The expiry date refers to the intact and properly preserved product. Wash your hands well before using your medical device. RIGENOMA BENDAGGIO with Ozoile is well tolerated. Awareness and side effects are not known today. Do not use in case of proven hypersensitivity to the product or some of its components; in case such phenomena occur it is indicated to suspend treatment and consult the doctor.
Conservation
Store in a cool and dry place from heat sources and direct sunlight. Preferably store between 5 °C and 35 °C.
Post-opening validation: six months.
Format
Pack containing 1 bandage of 10 cm x 5 m.
Cod. 51
